News | Brachytherapy Systems | January 05, 2017

Analysis Shows IORT Boost Effective Prior to Whole Breast Radiation

Results show low morbidity, excellent-to-good cosmetic results and low-grade adverse events for patients with early-stage breast cancer

iCAD, IORT boost, Xoft Axxent Electronic Brachytherapy System, intraoperative radiation therapy, whole breast radiation, early-stage breast cancer, SABCS 2016

January 5, 2017 — iCAD Inc. announced that researchers presented updated data on the use of intraoperative radiation therapy (IORT) with the Xoft Axxent Electronic Brachytherapy (eBx) System during the San Antonio Breast Cancer Symposium (SABCS), Dec. 6-10 in San Antonio, Texas. The data include results from a subset of patients who received IORT with the Xoft System as a boost prior to administration of whole breast radiation therapy (WBRT) in patients with early-stage breast cancer.

At the meeting, research was presented by Alam M. Nisar Syed, M.D., medical director, radiation oncology and endocurietherapy, Memorial Care Cancer Institute, Long Beach Memorial Medical Center. Syed’s findings include updated data on the treatment of 898 patients with early-stage breast cancer using IORT with the Xoft System at 26 hospitals in the United States and Portugal. The findings show that 90 percent of patients had excellent-to-good cosmesis with low rates of high-grade adverse events and recurrences two years post-treatment with Xoft IORT.

Of these 898 patients, 44 presented additional risk factors and were subsequently treated with WBRT, thus receiving an IORT boost dose prior to conventional treatment. This subset of patients was reviewed independently from the primary study, and Syed said he will continue to follow them as a separate subset for the duration of the 10-year study. The findings thus far show that IORT using the Xoft System as a tumor-bed boost at the time of lumpectomy is safe, with low morbidity, excellent-to-good cosmetic results and mostly low-grade adverse events.

“By identifying a subset of boost patients, our multi-center study not only showed positive clinical results, it highlighted the Xoft System’s versatility in the treatment of early-stage breast cancer,” said Syed. “IORT with the Xoft System offers patients many advantages, whether administered as monotherapy for smaller tumors or as a boost for women who require further treatment due to additional risk factors.”

For more information: www.xoftinc.com

Related Content

digital mammography trends, improved cancer detection, more biopsies, Radiology journal, BCSC study, Breast Cancer Surveillance Consortium
News | Mammography | February 23, 2017
The shift from film to digital technology appears to have improved cancer detection rates for diagnostic mammography,...
digital breast tomosynthesis, DBT, synthesized 2-D mammography, S2D, screening recall rates, Radiology journal study
News | Mammography | February 22, 2017
A new digital breast tomosynthesis technique has the potential to reduce the rate at which women are called back for...
Radiology journal, breast MRI screening, average risk women, breast cancer

Images in a 55-year-old screening participant. (a, b) Normal digital full-field mediolateral oblique (a) and craniocaudal (b) mammograms (BI-RADS category 1) show a heterogeneously dense breast (ACR category C). (c) Screening ultrasound image shows normal findings (BI-RADS category 1). (d) MR-guided biopsy enabled us to confirm the presence of an invasive high-grade triple-negative cancer (no special type [NST], pT1b, N0, M0). (d) Breast MR image shows a suspicious enhancing mass (arrow) in the left breast (BI-RADS category 5). Image courtesy of the Radiological Society of North America.

News | MRI Breast | February 21, 2017
Magnetic resonance imaging (MRI) screening improves early diagnosis of breast cancer in all women, not only those at...
fibroglandular breast density, breast cancer screening performance, Breast Cancer Research and Treatment study, Volpara Density
News | Breast Density | February 17, 2017
In the first large-scale study of its kind, Dutch researchers demonstrated a strong linear relationship between...
targeted radiosurgery, stereotactic radiosurgery, whole-brain radiation, brain tumor metastases, Cureus, University of Missouri School of Medicine study
News | Radiation Therapy | February 16, 2017
University of Missouri (MU) School of Medicine researchers compared two common postsurgical therapies for metastatic...
TMIST, lead-in study, tomosynthesis, mammography, The Ottawa Hospital Breast Health Centre, Canada
News | Breast Imaging | February 15, 2017
Researchers from The Ottawa Hospital Breast Health Centre and the Ottawa Integrative Cancer Centre (OICC) have opened...
ASTRO guideline, bone metastases, pallliative radiation therapy, gold standard
News | Radiation Therapy | February 14, 2017
February 14, 2017 — The American Society for Radiation Oncology (ASTRO) recently published an updated clinical guidel
Accuray, Radixact treatment delivery system, TomoTherapy, Shonin approval, Japan
News | Radiation Therapy | February 13, 2017
February 13, 2017 — Accuray Inc.
FDA, MQSA, mammography record retention and transfer
Feature | Mammography | February 13, 2017
The U.S. Food and Drug Administration (FDA) has released a new document detailing best practices for retaining patient...
Overlay Init